These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15841624)

  • 21. Cryoanalgesia with dichlorotetrafluoroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhidrosis.
    Baumann L; Frankel S; Welsh E; Halem M
    Dermatol Surg; 2003 Oct; 29(10):1057-9; discussion 1060. PubMed ID: 12974705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myobloc.
    Flynn TC
    Dermatol Clin; 2004 Apr; 22(2):207-11, vii. PubMed ID: 15222581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review.
    Campanati A; Diotallevi F; Radi G; Martina E; Marconi B; Bobyr I; Offidani A
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach.
    Campanati A; Giuliodori K; Giuliano A; Martina E; Ganzetti G; Marconi B; Chiarici A; Offidani A
    Arch Dermatol Res; 2013 Oct; 305(8):691-7. PubMed ID: 23800969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study.
    Kern U; Kohl M; Seifert U; Schlereth T
    Am J Phys Med Rehabil; 2011 Apr; 90(4):321-9. PubMed ID: 21765248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
    Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy of Botulinum Toxin A in Treating Palmar Hyperhidrosis - a Literature Review.
    Rashaan R; Arkoumanis PT
    Maedica (Bucur); 2023 Dec; 18(4):712-717. PubMed ID: 38348073
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
    Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
    Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral forearm intravenous regional anesthesia with prilocaine for botulinum toxin treatment of palmar hyperhidrosis.
    Bosdotter Enroth S; Rystedt A; Covaciu L; Hymnelius K; Rystedt E; Nyberg R; Naver H; Swartling C
    J Am Acad Dermatol; 2010 Sep; 63(3):466-74. PubMed ID: 20708471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of objective methods to diagnose palmar hyperhidrosis and monitor effects of botulinum toxin treatment.
    Krogstad AL; Skymne BS; Göran Pegenius BS; Elam M; Wallin BG
    Clin Neurophysiol; 2004 Aug; 115(8):1909-16. PubMed ID: 15261869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
    Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
    J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual Limb Hyperhidrosis and RimabotulinumtoxinB: A Randomized Placebo-Controlled Study.
    Pasquina PF; Perry BN; Alphonso AL; Finn S; Fitzpatrick KF; Tsao JW
    Arch Phys Med Rehabil; 2016 May; 97(5):659-664.e2. PubMed ID: 26812182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.
    Dressler D; Benecke R
    Eur Neurol; 2003; 49(1):34-8. PubMed ID: 12464716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.